Endurance Horse Positive for Banned, Controlled Substances

The Jordanian horse tested positive for boldenone, dexamethasone, meloxicam, phenylbutazone, and oxyphenbutazone.

No account yet? Register


The Fédération Equestre Internationale (FEI) has announced an adverse analytical finding involving prohibited substances in a Jordanian endurance horse.

Samples taken at the 80km CEI*1 in Amman, Jordan, on May 21, from Obama Al Aswad—who placed second with rider Nayef Al Fayez—have returned positive for the banned substance boldenone and the controlled medications dexamethasone, meloxicam, phenylbutazone, and oxyphenbutazone (a metabolite of phenylbutazone).

Boldenone, an anabolic steroid, is a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations. The corticosteroid dexamethasone is used to treat inflammatory and autoimmune conditions, while the non-steroidal anti-inflammatory drugs meloxicam, phenylbutazone, and its metabolite oxyphenbutazone are used for pain relief.

The athlete has been provisionally suspended from the date of notification (June 20). The horse has also been provisionally suspended for a two-month period

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.


Written by:

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

Where do you go to find information on pituitary pars intermedia dysfunction (PPID)? Select all that apply.
77 votes · 134 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!